Bailard Inc. Purchases 1,449 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bailard Inc. lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) by 47.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,509 shares of the exchange traded fund’s stock after acquiring an additional 1,449 shares during the period. Bailard Inc.’s holdings in SPDR S&P Biotech ETF were worth $505,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Axiom Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $25,000. Ancora Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 89.3% during the third quarter. Ancora Advisors LLC now owns 248 shares of the exchange traded fund’s stock valued at $31,000 after purchasing an additional 117 shares during the last quarter. EPG Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $33,000. Aptus Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $41,000. Finally, First Horizon Advisors Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 3,888.9% during the third quarter. First Horizon Advisors Inc. now owns 359 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 350 shares during the last quarter.

XBI opened at $68.46 on Tuesday. The firm has a 50 day moving average price of $83.42 and a 200-day moving average price of $98.08. SPDR S&P Biotech ETF has a twelve month low of $61.78 and a twelve month high of $141.50.

SPDR S&P Biotech ETF Profile (Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.